MedTech News
Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the Evoke® SmartLoop™ System
MINNEAPOLIS, July 17, 2025 /PRNewswire/ — Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, today announced the full commercial launch of EVA, its next-generation sensing technology, in the United States (U.S.). EVA received U.S. Food & Drug Administration (FDA) approval in December 2024 and is compatible with all commercially implanted Evoke® SmartLoop™ System patients.
Johnson & Johnson wins FDA priority review for drug delivery system
Johnson & Johnson (NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.
New Cannibalistic Robots Consume Other Machines to Grow and Heal on Their Own
Learn how “robot metabolism” allows machines to take material from their surroundings to “grow” and to “heal.”
Researchers try new ways of preserving more hearts for transplants
Two university hospitals are pioneering new ways to expand lifesaving heart transplants for adults and babies—advances that could help recover would-be heart donations that too often go unused.
Ultra-high-resolution MRI maps brain fibers and cells with near-micron precision
A scientific team supported in part by the National Institutes of Health (NIH) has developed a new, ultra-high-resolution brain imaging system that can reconstruct microscopic brain structures that are disrupted in neurological and neuropsychiatric brain disorders.
New technique could increase infant heart transplants by 20%
Duke Health has pioneered a world’s-first technique that could expand the donor pool for pediatric heart transplants in the U.S. by up to 20%—offering new hope to families on the waitlist.
New technology successfully monitors cancer progression at the cellular level
Sensome, the pioneer of microsensing technology for real-time, in situ tissue analysis, today announced the publication of a study in Science Advances unveiling an innovative methodology using its technology to noninvasively monitor cell spatiotemporal dynamics involved in cancer progression in a real-time and label-free manner, which can provide new insights for cancer diagnosis and treatment.
Global study shows longer brain scans lower research costs, provide more accurate predictions
Artificial intelligence (AI) models trained on large datasets are increasingly seen as the key to unlocking personalized treatments for brain disorders. An important bottleneck for scaling AI is the cost of data collection. This raises a fundamental dilemma: is it more cost-effective to scan more people for a short time, or fewer people for longer?